The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Uveal melanoma patients (pts) treated with abbv-075 (mivebresib), a pan-inhibitor of bromodomain and extraterminal (BET) proteins: Results from a phase 1 study.
 
Sapna Pradyuman Patel
Stock and Other Ownership Interests - Provectus
Honoraria - PCME, Rockpointe; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Cardinal Health; Castle Biosciences; Incyte
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Castle Biosciences; Incyte; Massachusetts General Hospital; PCME, Rockpointe; Socrates Analytics
 
Johannes E. Wolff
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
Travel, Accommodations, Expenses - AbbVie
 
Rosa Margarita Mostorino
No Relationships to Disclose
 
Xiaotian Chen
Employment - AbbVie
Travel, Accommodations, Expenses - AbbVie
 
Mark D. McKee
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Sarina Anne Piha-Paul
Consulting or Advisory Role - Genentech
Research Funding - Abbvie; Bayer; BlueLink; Curis; Five Prime Therapeutics; GlaxoSmithKline; Helix BioPharma; Incyte; MedImmune; Medivation; Merck Sharp & Dohme; Novartis; Pfizer; Pieris Pharmaceuticals; Principa Biopharma; Puma Biotechnology; Tesaro; XuanZhu